Brief: Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement With Cook Myosite
17/04/2023 13:32
April 17 (Reuters) - Lipella Pharmaceuticals Inc
LIPO.O :
* LIPELLA PHARMACEUTICALS ENTERS MANUFACTURING COLLABORATION
AGREEMENT WITH COOK MYOSITE
* LIPELLA PHARMACEUTICALS INC - LIPELLA TO COLLABORATE IN
ANTICIPATION OF FORTHCOMING INVESTIGATIONAL NEW DRUG (IND)
APPLICATION
* LIPELLA PHARMACEUTICALS INC - LP-10 IS A PROMISING
POTENTIAL
TREATMENT FOR HEMORRHAGIC CYSTITIS THAT HAS RECEIVED ORPHAN DRUG
DESIGNATION FROM FDA
Source text for Eikon: ID:nPn7SzbLqa
Further company coverage: LIPO.O
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group